CDSCO Panel Approves Updated Package Insert for Takeda's Vedolizumab Susmita Roy5 Nov 2025 4:16 PM ISTNew Delhi: In a key regulatory development, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has...
Ziller Medical Denied Manufacturing Nod for Cervical Cerclage Pessary Over Inadequate Safety Data Parthika Patel4 Nov 2025 4:49 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has refused to grant manufacturing...
CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin Study Susmita Roy4 Nov 2025 4:39 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in...
Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017 Susmita Roy3 Nov 2025 9:07 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has released a detailed Risk Classification List of Class A (non-sterile and...
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment Susmita Roy3 Nov 2025 7:08 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for...
Akums Wins 20-Year Patent for Dual Release PPI, Promises Long-Lasting GERD Relief Farhat Nasim3 Nov 2025 6:02 PM ISTNew Delhi: Akums Drugs and Pharmaceuticals Limited has announced that it has been granted a patent for its invention titled 'Dual Release...
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients Susmita Roy2 Nov 2025 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has approved MSN Laboratories to conduct a...
Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone Tablets Parthika Patel2 Nov 2025 11:30 AM ISTNew Delhi: Pune-based Emcure Pharmaceuticals Ltd has received a recommendation from the Subject Expert Committee (SEC) under the Central Drugs...
Nearly 50% of Drug Inspector Posts Vacant at CDSCO, Reveals RTI Response Susmita Roy1 Nov 2025 10:22 PM ISTNew Delhi: Nearly 250 Drug Inspector posts remain vacant across the regulatory and medical device divisions of the Central Drugs Standard Control...
Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin Susmita Roy1 Nov 2025 5:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has directed Boehringer Ingelheim India to...
MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis Parthika Patel1 Nov 2025 5:25 PM ISTNew Delhi: Hyderabad-based MSN Laboratories Pvt Ltd has received a recommendation from the Subject Expert Committee (SEC) under the Central Drugs...
CDSCO Panel Seeks Anesthesiology Expert Review for AIIMS Raipur Trial on Gabapentin, Melatonin, Clonidine FDC Susmita Roy31 Oct 2025 7:26 PM ISTNew Delhi: After reviewing a clinical trial proposal submitted by Dr Pratibha R Mudgal from AIIMS Raipur, involving a fixed-dose combination of...
